Announce Date | 02/26/2025 |
EPS Normalized Actual | $0.89 (Beat by $0.045) |
EPS GAAP Actual | $0.89 (Beat by $0.045) |
Revenue Actual | $39.331B |
Revenue Surprise | Beat by $39331M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 6.96 | 13.55 | 5.51799 | 9.10887 | 5 |
Jan 2029 | 42.01 | 2.24 | 35.46431 | 55.7461 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 0.9 | 0.9 | 39.331B | 43.8% | 39331M |
FQ4 2024 (Oct 2024) | 0.79 | 0.79 | 35.082B | 48.35% | 35082M |
FQ3 2024 (Jul 2024) | 0.68 | 0.68 | 30.04B | 55.04% | 30040M |
FQ2 2024 (Apr 2024) | 6.04 | 6.04 | 26.044B | 72.39% | 26044M |
FQ1 2024 (Jan 2024) | 4.9818 | 4.9818 | 22.103B | 72.62% | 22103M |
FQ4 2023 (Oct 2023) | 3.75 | 3.75 | 18.12B | 67.27% | 18120M |
FQ3 2023 (Jul 2023) | 2.5 | 2.5 | 13.507B | 50.37% | 13507M |
FQ2 2023 (Apr 2023) | 0.83 | 0.83 | 7.192B | 100% | 7192M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 1.70496 | -- | 1.64844 | 1.88491 | 18 |
FQ4 2027 (Oct 2027) | 1.54071 | -- | 1.48964 | 1.70332 | 19 |
FQ3 2027 (Jul 2027) | 1.40878 | -- | 1.36208 | 1.55747 | 17 |
FQ2 2027 (Apr 2027) | 1.33382 | -- | 1.2896 | 1.4746 | 17 |
FQ1 2027 (Jan 2027) | 1.50707 | -- | 1.45711 | 1.66613 | 17 |
FQ4 2026 (Oct 2026) | 1.45258 | -- | 1.40443 | 1.60589 | 17 |
FQ3 2026 (Jul 2026) | 1.393 | -- | 1.34682 | 1.54002 | 17 |
FQ2 2026 (Apr 2026) | 1.33576 | -- | 1.29148 | 1.47674 | 17 |
FQ1 2026 (Jan 2026) | 1.34458 | 33.06 | 1.30001 | 1.48649 | 34 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 70.3B | -- | 68.51B | 76.01B | 28 |
FQ4 2027 (Oct 2027) | 64.29B | -- | 62.65B | 69.51B | 18 |
FQ3 2027 (Jul 2027) | 59.43B | -- | 57.92B | 64.26B | 25 |
FQ2 2027 (Apr 2027) | 56.69B | -- | 55.25B | 61.29B | 18 |
FQ1 2027 (Jan 2027) | 65.41B | -- | 63.74B | 70.72B | 18 |
FQ4 2026 (Oct 2026) | 63.12B | -- | 61.51B | 68.25B | 18 |
FQ3 2026 (Jul 2026) | 60.55B | -- | 59.01B | 65.47B | 33 |
FQ2 2026 (Apr 2026) | 58.27B | -- | 56.78B | 63B | 21 |
FQ1 2026 (Jan 2026) | 58.77B | 33.07 | 57.27B | 63.54B | 18 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 0.9 | 0.9 | 100% | |
FQ4 2024 (Oct 2024) | 0.79 | 0.79 | 100% | |
FQ3 2024 (Jul 2024) | 0.68 | 0.68 | 100% | |
FQ2 2024 (Apr 2024) | 6.04 | 6.04 | 100% | |
FQ1 2024 (Jan 2024) | 4.9818 | 4.9818 | 100% | |
FQ4 2023 (Oct 2023) | 3.75 | 3.75 | 100% | |
FQ3 2023 (Jul 2023) | 2.5 | 2.5 | 100% | |
FQ2 2023 (Apr 2023) | 0.83 | 0.83 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $39.33B | $39331M | 100% |
FQ4 2024 (Oct 2024) | $0B | $35.08B | $35082M | 100% |
FQ3 2024 (Jul 2024) | $0B | $30.04B | $30040M | 100% |
FQ2 2024 (Apr 2024) | $0B | $26.04B | $26044M | 100% |
FQ1 2024 (Jan 2024) | $0B | $22.1B | $22103M | 100% |
FQ4 2023 (Oct 2023) | $0B | $18.12B | $18120M | 100% |
FQ3 2023 (Jul 2023) | $0B | $13.51B | $13507M | 100% |
FQ2 2023 (Apr 2023) | $0B | $7.19B | $7192M | 100% |